1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPatient Assistance Programs (Disease-Specific Financial Assistance) is sponsored by The PAN Foundation. The PAN Foundation provides financial assistance to help underinsured people with life-threatening, chronic, and rare diseases across every U. S.
state and territory. They have more than 70 disease-specific financial assistance funds, with over 25 rare diseases.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Patient Advocate Foundation - Patient financial assistance, advocacy, and education Important: Patient Advocate Foundation’s TotalAssist program launches on July 1. Whether you’re a new patient, or you’re currently receiving assistance from Patient Advocate Foundation or PAN Foundation, visit our TotalAssist. org website to learn more about next steps, get helpful information, and access your portal account.
Starting July 1, t he call center can be reached by calling toll free, 866-512-3861 from 8:30am to 5:30pm ET. Following the March 2026 strategic merger, Patient Advocate Foundation and PAN Foundation are now one organization. TotalAssist —our unified financial assistance program—is now available to patients nationwide.
TotalAssist is here to help with your healthcare costs. TotalAssist is the nation’s most comprehensive charitable patient financial assistance program—covering nearly 150 serious and chronic conditions. Whether you’re a new patient, or you’re currently receiving assistance from Patient Advocate Foundation or PAN Foundation, visit our TotalAssist.
org website for information and next steps. Our financial assistance programs give you the funds you need to afford medication copays and health insurance premiums. Find your disease fund, check your eligibiity, and apply online today.
I’m so grateful for what they’ve done for me and others. They’ve kept me alive. ” Scott shares his story about living with multiple sclerosis, receiving a copay grant, and advocating for better healthcare access for all.
Important information about this website This website is now part of Patient Advocate Foundation as a result of the 2026 strategic merger and will be active during our full website transition. Where to find information during our transition: → About the merged organization: uniting. patientadvocate.
org → Financial assistance: totalassist. org → Additional direct patient services and resources: patientadvocate. org → Education: panfoundation.
org and education. patientadvocate. org → Clinical trials education: clinicaltrials.
panfoundation. org → Research: patientinsightinstitute. org Learn about new programs, advocate for healthcare access, and get our latest educational resources.
Explore our comprehensive educational resources We offer guides, resources, and tips to help you navigate, access, and afford care Kevin: community pharmacists are part of the solution Patient Advocate Foundation launches TotalAssist, nation’s largest and most comprehensive charitable patient assistance program Patient Advocate Foundation leadership appointments take effect following strategic nonprofit merger Patient Advocate Foundation and PAN Foundation announce merger to create nation’s most comprehensive nonprofit dedicated to helping patients navigate, access, and afford care Send help to people who need treatment today.
It's been a true relief. And now I take my medication without worrying about it, without stretching it for an extra week. Thank you, PAN Foundation.
I don’t know where I’d be without you. ” Arlene Burman, from Maryland, living with Crohn's disease
According to the current listing, eligibility includes: Underinsured patients with life-threatening, chronic, and rare diseases. Eligibility typically based on income (e. g. , in 2024, a one-person household earning less than $75,300 per year may be eligible). Confirm the full requirements in the official notice before applying.
Patient Assistance Programs (Disease-Specific Financial Assistance) is funded by The PAN Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Mentored Clinical Research Award (MCRA) supports patient-oriented vision injury research conducted by highly motivated military or civilian clinicians in training. The MCRA may be used to support a standalone study of high impact to vision injury care or the generation of clinical research data in preparation for a more expansive study. Research must align with at least one of the FY26 VRP Focus Areas. The MCRA may not be used to support preclinical research or clinical trials. Distinctive Features: · Key personnel must include an established clinician or Ph.D. clinical scientist, who will serve as Principal Investigator (PI) and a clinician in training (e.g., a fellow, resident, junior clinician, clinician in a Ph.D. program), who will conduct the proposed research under mentorship of the PI, with support from supporting personnel as appropriate. · The clinician in training should have sufficient time remaining in their training program to complete the research proposed under the MCRA. · Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact and Personnel. · Programmatic review criteria include adherence to the intent of the MCRA, contribution to program portfolio, relative impact and relevance to military health. · Applicants must submit documentation of Institutional Review Board (IRB)/Ethics Committee (EC) approval or exemption by January 1, 2027, in order for the MCRA application to be considered for funding. https://cdmrp.health.mil/pubs/press/2026/vrppreann Funding Opportunity Number: HT942526VRPMCRA. Assistance Listing: 12.420. Funding Instrument: G. Category: ST. Award Amount: $150K total program funding.
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Platform Clinical Translation Award supports the translational development and/or early-phase clinical trials for broadly applicable clinical technologies that will address urgent and complex needs related to two congressionally directed FY26 PRMRP topic areas. The platform product in development should address one of the FY26 PRMRP portfolio-specific strategic goals and address the health care needs of military Service Members, Veterans and their Families.Distinctive Features:Allows for multiple Principal Investigators (PIs). The proposed experiments may represent a single project led by a single PI, or it may consist of partnerships between principal investigators that will occur synergistically to advance a platform product. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. Up to two additional PIs can be identified as Partnering PIs. If recommended for funding, each PI will be named on separate awards to the recipient organization(s).Requires a PI-convened external advisory board with patient advocate participation. The patient advocate must be a person living with, or a family member or caretaker of someone with, a disease or condition addressed in one of the applicant-selected congressionally directed FY26 PRMRP topic areas.Funding Details: The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $30M to fund approximately two Platform Clinical Translation Award applications with total cost caps of $15M per award. The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with a maximum of $8M in FY26, with the remaining budget to be funded out of future fiscal years depending upon meeting performance-based milestones and availability of future funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027. Funding Opportunity Number: HT942526PRMRPPCTA. Assistance Listing: 12.420. Funding Instrument: CA,G. Category: ST. Award Amount: $30M total program funding.